|BSE: 500257||Sector: Health care|
|NSE: LUPIN||ISIN Code: INE326A01037|
|BSE 00:00 | 24 Apr 2020||Lupin Ltd|
|NSE 05:30 | 01 Jan 1970||Lupin Ltd|
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMarch 27, 2020, 7:52 pm | Source: BSE
Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto? Biosimilar Etanercept.